The microbiota and the gut–liver axis in primary sclerosing cholangitis

JR Hov, TH Karlsen - Nature Reviews Gastroenterology & Hepatology, 2023 - nature.com
Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut–liver axis
owing to the close association between liver disease and colonic inflammation. It is well …

Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation

S Zundler, C Günther, AE Kremer, MM Zaiss… - Nature Reviews …, 2023 - nature.com
Immune cell trafficking is a complex and tightly regulated process that is indispensable for
the body's fight against pathogens. However, it is also increasingly acknowledged that …

EASL Clinical Practice Guidelines on sclerosing cholangitis

O Chazouilleres, U Beuers, A Bergquist, TH Karlsen… - Journal of …, 2022 - Elsevier
Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

CL Bowlus, L Arrivé, A Bergquist, M Deneau… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease

H Gordon, J Burisch, P Ellul, K Karmiris… - Journal of Crohn's …, 2024 - academic.oup.com
This is the second European Crohn's and Colitis Organisation [ECCO] evidence-based
consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and …

[HTML][HTML] Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence

A Mertz, NA Nguyen, KH Katsanos… - Annals of …, 2019 - ncbi.nlm.nih.gov
Comorbid primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD)
represent a unique disease phenotype with a different risk profile than PSC or IBD alone …

Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities

M Vesterhus, TH Karlsen - Journal of gastroenterology, 2020 - Springer
Primary sclerosing cholangitis (PSC) is a progressive liver disease, histologically
characterized by inflammation and fibrosis of the bile ducts, and clinically leading to multi …

[HTML][HTML] Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases

KD Lynch, RW Chapman, S Keshav… - Clinical …, 2020 - Elsevier
Background & Aims Gut-homing lymphocytes that express the integrin α4β7 and CCR9
might contribute to development of primary sclerosing cholangitis (PSC). Vedolizumab …

[PDF][PDF] Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis

JJ Graham, S Mukherjee, M Yuksel… - …, 2022 - Wiley Online Library
Abstract Background and Aims The “gut homing” hypothesis suggests the pathogenesis of
primary sclerosing cholangitis (PSC) is driven by aberrant hepatic expression of gut …

Novel and emerging therapies for cholestatic liver diseases

J Goldstein, C Levy - Liver International, 2018 - Wiley Online Library
While bile acids are important for both digestion and signalling, hydrophobic bile acids can
be harmful, especially when in high concentrations. Mechanisms for the protection of …